Just in time! Identification of a novel mechanism for treating PIPN
- 11 May 2020
- journal article
- editorial
- Published by Wiley
- Vol. 598 (12), 2283-2284
- https://doi.org/10.1113/JP279863
Abstract
No abstract availableKeywords
Funding Information
- National Institute on Drug Abuse (DA042852)
This publication has 8 references indexed in Scilit:
- Distinct roles of srGAP3‐Rac1 in the initiation and maintenance phases of neuropathic pain induced by paclitaxelThe Journal of Physiology, 2020
- Pathogenesis of paclitaxel-induced peripheral neuropathy: A current review of in vitro and in vivo findings using rodent and human model systemsExperimental Neurology, 2019
- In vivo proximity proteomics of nascent synapses reveals a novel regulator of cytoskeleton-mediated synaptic maturationNature Communications, 2019
- Patient-Reported Toxicities During Chemotherapy Regimens in Current Clinical Practice for Early Breast CancerThe Oncologist, 2018
- Etiology and Pharmacology of Neuropathic PainPharmacological Reviews, 2018
- Dendritic spine dysgenesis in neuropathic painNeuroscience Letters, 2015
- SrGAP3 interacts with lamellipodin at the cell membrane and regulates Rac-dependent cellular protrusionsJournal of Cell Science, 2011
- Evidence for a central component of post-injury pain hypersensitivityNature, 1983